Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medlive Technology CoHKSE:02192 +0.90%90 FCF Yield % is 2.29 as of Aug. 03, 2026, which is 104% above its 10-year median of 1.12. GuruFocus rates HKSE:02192 with a GF Score™ of 90/100 and a GF Value™ of HK$14.95 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 682 Healthcare Providers & Services companies, Medlive Technology Co ranks better than 53.08% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Medlive Technology Co's FCF Yield % or its related term are showing as below:
HKSE:02192'
s FCF Yield % Range Over the Past 10 Years
Min: 0.3 Med: 1.12 Max: 2.82
Current: 2.29
During the past 8 years, the highest FCF Yield % of Medlive Technology Co was 2.82%. The lowest was 0.30%. And the median was 1.12%.
HKSE:02192's FCF Yield % is ranked better than 53.08% of 682
companies
in the Healthcare Providers & Services industry
Industry Median: 1.845
vs HKSE:02192: 2.29
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Medlive Technology Co FCF Yield % Related Terms
Medlive Technology Co FCF Yield % Historical Data
* Premium members only.
The historical data trend for Medlive Technology Co's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02192 vs VEEV, BTSG, HQY: FCF Yield % Comparison
For the Health Information Services subindustry, Medlive Technology Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medlive Technology Co FCF Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medlive Technology Co's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Medlive Technology Co's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medlive Technology Co (HKSE:02192) has a FCF Yield % of 2.29 as of Aug. 03, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Medlive Technology Co and its competitors. This is 104% above median its historical median of 1.12. Over the past decade, Medlive Technology Co's FCF Yield % has ranged from 0.30 to 2.82. According to the industry distribution chart, Medlive Technology Co ranks #320 out of 682 companies in the Healthcare Providers & Services industry, placing it in the top 46.9%.
Is Medlive Technology Co's FCF Yield % too high?
Medlive Technology Co's current FCF Yield % of 2.29 is 104% above median its 10-year median of 1.12. Over the past 10 years, this metric has ranged from a low of 0.30 to a high of 2.82. The Healthcare Providers & Services industry median FCF Yield % is 1.85. Medlive Technology Co's value of 2.29 is 24.1% above this industry median. Based on the distribution chart, Medlive Technology Co ranks #320 out of 682 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Medlive Technology Co has a GF Score™ of 90/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medlive Technology Co's FCF Yield % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Medlive Technology Co ranks #320 out of 682 companies for FCF Yield %. This puts Medlive Technology Co in the upper half of its industry. The industry median FCF Yield % is 1.85. Medlive Technology Co's value of 2.29 is 24.1% above this benchmark. Historically, Medlive Technology Co's own FCF Yield % has ranged from 0.30 to 2.82 over the past decade. While the company's 10-year median is 1.12 vs. the industry median of 1.85, Medlive Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Healthcare Providers & Services company?
The median FCF Yield % among Healthcare Providers & Services companies is 1.85, based on 682 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medlive Technology Co's current FCF Yield % of 2.29 is 24.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Medlive Technology Co and its competitors. For the Healthcare Providers & Services industry, the median FCF Yield % is 1.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medlive Technology Co's current FCF Yield % is 2.29, which is 104% above median its own 10-year median of 1.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medlive Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Medlive Technology Co (HKSE:02192) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$14.95, compared to a current price of HK$7.87 — trading 47.4% below its estimated fair value. The current FCF Yield % is 2.29, which is 104% above median its 10-year median of 1.12 and 24.1% above the Healthcare Providers & Services industry median of 1.85. Medlive Technology Co's overall GF Score™ is 90/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Medlive Technology Co (HKSE:02192), the current FCF Yield % is 2.29 as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medlive Technology Co (HKSE:02192) Overvalued in 2026?
Based on GuruFocus' analysis, Medlive Technology Co stock appears to be undervalued.
The current stock price of HK$7.87 is trading 47.4% below its estimated GF Value™ of HK$14.95.
GuruFocus considers Medlive Technology Co to be Significantly Undervalued.
Key valuation signals for HKSE:02192:
FCF Yield %: 2.29 (104% above median its 10-year median of 1.12)
GF Value™: HK$14.95 vs. price of HK$7.87 (47.4% below fair value)
Industry Position: 24.1% above the Healthcare Providers & Services median (#320 of 682)
No single metric tells the full story. See the HKSE:02192 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medlive Technology Co Ltd is a digital healthcare marketing company that produces customized content for pharmaceutical and medical device firms. The company developed into a professional provider of medical information services and precision digital marketing services. Its platform also provides medical content consisting of third-party research, informal discussions, and medical news articles. The company also operates a minor internet hospital and a SaaS solution that helps with medical conferences and clinical research.
90GF Score
Get the complete analysis for HKSE:02192
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02192 has been successfully added to your 
